Hydrocephalus in Children
10
0
1
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
20.0%
2 terminated out of 10 trials
75.0%
-11.5% vs benchmark
10%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Efficacy and Cost-Effectiveness of Topical Vancomycin Powder in Preventing Pediatric Ventriculoperitoneal Shunt Infections Across Different Etiologies
Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve
Precision Surgery for Pediatric Hydrocephalus: VPS vs. ETV With ML-Guided Prediction
Barriers to Patients' Early Presentation, Diagnosis and Treatment in Childhood Hydrocephalus
The Effect of Education Given to Parents of Children With Ventriculoperitoneal Shunt on Their Anxiety and Self-efficacy
Scalp Blocks for Pediatric External Ventricular Drainage Placement
Hydrocephalus iPad-App Based Intervention Study
Myelin Imaging Changes In Patients With Neurosurgical Diseases
A Secondary Study Evaluating Aqueduct's Smart External Drain (SED)
A Study Evaluate Aqueduct's Smart External Drain